Azkar
0подписчиков
•1подписка
Я тут просто посмотреть...
Портфель
до 500 000 ₽
Сделки за 30 дней
1
Доходность за 12 месяцев
−2,83%
Не является индивидуальной инвестиционной рекомендацией
Делитесь опытом в Пульсе
Как больше зарабатывать и эффективнее тратить
Публикации
Ролики
$SPCE
Акции вернулись на уровень месячной давности. Какая же стабильная бумажка, молодца!
2
Нравится
Комментировать
{$CVM}
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available
July 02, 2021
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced that the discussion at the Annual Shareholder Meeting, on July 1, 2021 at 10:00 am EDT, regarding its Phase 3 head and neck cancer trial results is available at https://edge.media-server.com/mmc/p/ou79u5bv.
The discussion on the Phase 3 results was presented by Geert Kersten the Chief Executive Officer, Dr. Eyal Talor the Chief Scientific Officer and John Cipriano the Senior Vice President of Regulatory Affairs. In the landmark Phase 3 study, Multikine® produced a significant 14.1% 5-year survival benefit (62.7% vs 48.6%) in the group of advanced primary head and neck cancer patients who received surgery plus radiotherapy. The Company plans to file for FDA approval in this patient population.
1
Нравится
12
